ReviewClinical research in cardiology : official journal of the German Cardiac Society2026
Perioperative atrial fibrillation after non-cardiac surgery - A narrative review.
Review in Clinical research in cardiology : official journal of the German Cardiac Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Perioperative atrial fibrillation (POAF) in non-cardiac surgery (NCS) is a multifactorial condition with significant prognostic implications. This review summarizes current evidence on the incidence, risk factors, pathophysiology, complications, prevention, and management of POAF in NCS. POAF affects around 3% of all patients undergoing NCS, with rates of 10-15% in thoracic procedures. Key risk factors include advanced age, male sex, pre-existing cardiopulmonary diseases, type, duration, and urgency of surgery as well as perioperative inflammation. Pathophysiological mechanisms are not fully understood but may include gap junction uncoupling triggered by inflammation, ischemia, and autonomic imbalance. POAF in NCS is associated with increased risks of stroke, heart failure, progression to chronic atrial fibrillation and mortality. Available data on patient-reported symptoms, functional status and quality of life are sparse. Preventive strategies and treatment options for POAF after NCS are limited and not standardized. Large trials are needed to define the efficacy and safety of anticoagulation, rhythm control and other treatments.
Indexed as
Identifiers
42053827What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.